Age-related congophilic inclusions in the brains of apolipoprotein e- deficient mice

Neuroscience

Volumn 82, Issue 1, 1997, Pages 171-180

  Robertson, T A ^a   Dutton, N S ^a   Martins, R N ^d   Roses, A D ^b   Kakulas, B A ^a,c   Papadimitriou, J M ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c QE2 Medical Centre   (Australia)

^d NONE

Author keywords

amyloid; Apolipoprotein E; Astrocytes; Hippocampus; Histochemistry; Mice

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; CONGO RED; MONOCLONAL ANTIBODY; SYNTHETIC PEPTIDE;

ADOLESCENT; AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GRANULE; CELL INCLUSION; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HYPERLIPOPROTEINEMIA TYPE 3; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

AGING; AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODIES, MONOCLONAL; APOLIPOPROTEINS E; BRAIN; COLORING AGENTS; CONGO RED; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, NEUROLOGIC MUTANTS; MICROSCOPY, ELECTRON; NERVE DEGENERATION;

EID: 0030928975     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00284-4     Document Type: Article

References (51)

1. Akiyama H., Kameyama M., Akiguchi I., Sugiyama H., Kawamata T., Fukuyama H., Kimura H., Matsushita M., Takeda T. Periodic acid Schiff (PAS)-positive granular structures increase in the brain of senescence accelerated mouse (SAM). Acta neuropath. 72:1986;124-129.
2. Askanas V., Engel W. K., Renate B., Alverez M. S. Enhanced detection of Congo red-positive amyloid deposits in muscle fibres of inclusion body myositis and brain of Alzheimer's disease using fluorescence technique. Neurobiology. 43:1993;1265-1267.
3. Behrman S., Carrol J. D., Janota I., Matthews W. B. Progressive supranuclear palsy. Clinico-pathological study of four cases. Brain. 92:1969;663-678.
4. Brawer J. R., Reichard G., Small L., Schipper H. M. The origin and composition of peroxidase-positive granules in cysteamine-treated astrocytes in culture. Brain Res. 633:1994;9-20.
5. Chartier-Harlin M. C., Parfitt M., Legrain S., Perez-Tur J., Brousseau T., Evans A., Berr C., Vidal O., Roques P., Goulet V. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Human molec. Genet. 3:1994;569-574.
6. Cisse S., Schipper H. M. Experimental induction of corpora amylacea-like inclusions in rat astroglia. Neuropath. appl. Neurobiol. 21:1995;423-431.
7. Corder E. H., Saunders A. M., Risch N. J., Strittmatter W. J., Schmechel D. E., Gaskell P. R. Jr., Rimmler J. B., Locke P. A., Conneally P. M., Schmader K. E. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet. 7:1994;180-184.
8. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
9. Fleming P. D., Rogers J. Neuropathology of olfactory system in Alzheimer's disease and normal aging. Soc. Neurosci. Abstr. 12:1986;1314.
10. Fleming P. D., Cordoza M. E., Woods S. G. Corpora amylacea increased with Alzheimer's disease. Neurology. 12(Suppl. 1):1987;157.
11. Gambetti P., DiMauro S., Hirt L., Blume R. P. Myoclonic epilepsy with Lafora bodies: some ultrastructural, histochemical and biochemical aspects. Archs neurol. 25:1971;483-493.
12. Genis I., Gordon I., Sehayek E., Michaelson D. M. Phosphorylation of tau in apolipoprotein E-deficient mice. Neurosci. Lett. 199:1995;5-8.
13. Glenner G. G., Wong C. W. Alzheimers disease: initial report of the purification and characterisation of a novel cerebrovascular amyloid protein. Biochem. biophys. Res. Commun. 120:1984;885-890.
14. Goldgaber D., Schwarzman A. I., Bhasin R., Gregori L., Schmechel D., Saunders A. M., Roses A. D., Strittmatter W. J. Sequestration of amyloid β-peptide. Ann. N. Y. Acad. Sci. 695:1993;139-143.
15. Gordon I., Grauer E., Genis I., Sehayek E., Michaelson D. M. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci. Lett. 199:1995;1-4.
16. Houlden H., Crook R., Hardy J., Roques P., Collinge J., Rossor M. Confirmation that familial clustering and age of onset in late onset Alzheimer's disease are determined at the apolipoprotein E locus. Neurosci. Lett. 174:1994;222-224.
17. Janeway R., Ravens J. R., Pearce L. A., Odor D. L., Suzuki K. Progressive myoclonic epilepsy with Lafora inclusion bodies: clinical, genetic, histopathologic and biochemical aspects. Archs neurol. 16:1967;565-582.
18. Johnstone E. M., Chaney M. O., Norris F. H., Pascual R., Little S. P. Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. Molec. Brain Res. 10:1991;299-305.
19. Jucker M., Walker L. C., Schwarb P., Hengemihle J., Kuo H., Snow A. D., Bamer F., Ingram D. K. Age-related deposition of glia-associated fibrillar material in brains of C57BL/J mice. Neuroscience. 60:1994;875-889.
20. Jucker M., Walker L. C., Kuo H., Tian M., Ingram D. K. Age related fibrillar deposits in brains of C57BL/6 mice. Molec. Neurobiol. 9:1994;125-133.
21. Jucker M., Walker L. C., Martin L. J., Kitt C. A., Kleinman H. K., Ingram D. K., Price D. L. Age-associated inclusions in normal and transgenic mouse. Science. 255:1992;1443-1445.
22. Kim K. S., Miller D. L., Sapienza V. J., Chen C. M., Bai C., Grundke-Iqbal I., Currie J. R., Eisniewski H. M. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci. Res. Commun. 2:1988;121-130.
23. Lamar C. H., Hinsman E. J., Henrikson C. K. Alterations in the hippocampus of aged mice. Acta neuropath. 36:1976;387-391.
24. Ma J., Yee A., Brewer H. B. Jr., Das S., Potter H. Amyloid-associated proteins a2-antichymotrypsin and apolipoprotein E promote the assembly of the Alzheimer β-protein into filaments. Nature. 372:1994;92-94.
25. Mandybur T. I., Ormsby I., Zemlan F. P. Cerebral aging: a quantitative study of gliosis in old nude mice. Acta neuropath. 77:1989;507-513.
26. Martins R. N., Clarnette R., Fisher C., Broe G. A., Brooks W. S., Montgomery P., Gandy S. E. ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome. NeuroReport. 6:1995;1513-1516.
27. Masliah E., Mallory M., Ge N. F., Alford M., Veinbergs I., Roses A. D. Neurodegeneration in the central nervous system of ApoE-deficient mice. Expl Neurol. 136:1995;107-122.
28. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down's syndrome. Proc. natn. Acad. Sci. U.S.A. 82:1985;4245-4249.
29. McLaren J., Brawer J. R., Schipper H. M. Iron content correlates with peroxidase activity in cysteamine-induced astroglial organelles. J. Histochem. Cytochem. 40:1992;1887-1897.
30. Mydlarski M. B., Schipper H. M. Stress protein co-localisation to autofluorescent astrocytic inclusions in situ and in cysteamine-treated glial cells. Brain Res. 627:1993;113-121.
31. Nakashima Y., Plump A. S., Raines E. W., Breslow J. L., Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arteriosclerosis and Thrombosis. 14:1994;133-140.
32. Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541:1991;163-166.
33. Plump A. S., Smith J. D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J. G., Rubin E. M., Breslow J. L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:1992;343-353.
34. Quon D., Wang Y., Catalano R., Scardina J. M., Murakami K., Cordell B. Formation of β-amyloid protein deposits in brains of transgenic mice. Nature. 352:1991;239-241.
35. Richards S. J., Edwards P., Waters J., Dunnett S. B. Ultrastructural neuropathology in murine trisomy 16 hippocampal grafts. NeuroReport. 4:1993;208-210.
36. Robitaille Y., Carpenter S., Karpati G., DiMaurio S. A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes. Brain. 103:1980;315-336.
37. Roses A. D. Apolipoprotein E affects the rate of Alzheimers Disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J. Neuropath. exp. Neurol. 53:1994;429-437.
38. Saunders A. M., Schmader K., Breitner J. C., Benson M. D., Brown W. T., Goldfarb L., Goldgaber D., Manwaring M. G., Szymanski M. H., McCown N. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet. 342:1993;710-711.
39. Saunders A. M., Strittmatter W. J., Schmechel D., George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
40. Sbarbati A., Carner M., Colletti V., Osculati F. Extrusion of corpora amylacea from the marginal glia at the vestibular root entry zone. J. Neuropath. exp. Neurol. 55:1996;196-201.
41. Schipper H. M., Scarborough D. E., Lechan R. M., Reichlin S. Gomori-positive astrocytes in primary culture: Effects of in vitro age and cysteamine exposure. Devl Brain Res. 54:1990;71-79.
42. Schipper H. M., Cisse S., Walton P. A. Colocalisation of organelle-specific proteins to autofluorescent astrocyte granules by laser scanning confocal microscopy. Expl Cell Res. 207:1993;62-67.
43. Schipper H. M., Cisse S. Mitochondrial constituents of corpora amylacea and autofluorescent astrocytic inclusions in senescent human brain. Glia. 14:1995;55-64.
44. Schipper H. M. Gomori-positive astrocytes: biological properties and implications for neurologic and neuroendocrine disorders. Glia. 4:1991;365-377.
45. Stam F. C., Roukema P. A. Histochemical and biochemical aspects of corpora amylacea. Acta neuropath. 25:1973;95-102.
46. Tomlinson B. E. (1992) Ageing and the dementias. In Greenfield's Neuropathology (eds Adams J. H. and Duchen L. W.), pp. 1284-1410. Oxford University Press, New York.
47. Ueki A., Kawano M., Namba Y., Kawakami M., Ikeda K. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci. Lett. 163:1993;166-168.
48. Wirak D. O., Bayney R., Ramabhadran T. V., Fracasso R. P., Hart J. T., Hauer P. E., Hsiau P., Pekar S. K., Scangos G. A., Trapp B. D., Unterbeck A. J. Deposits of amyloid β protein in the central nervous system of transgenic mice. Science. 253:1991;323-325.
49. Wisniewski T., Castano E. M., Golabek A., Vogel T., Frangione B. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Path. 145:1994;1030-1035.
50. Young J. K., Garvey J. S., Huang P. C. Glial immunoreactivity for metallothionein in the rat. Glia. 4:1991;602-610.
51. Young J. K., Baker J. H., Muller T. Immunoreactivity for brain-fatty acid binding protein in gomori-positive astrocytes. Glia. 16:1996;218-226.